- January 19, 2017: Case Count Update
- Interim Recommendations for Healthcare Facilities and Laboratories
Candida auris is an emerging fungus that presents a serious global health threat. Healthcare facilities in several countries have reported that C. auris has caused severe illness in hospitalized patients. Some strains of Candida auris are resistant to all three major classes of antifungal drugs. This type of multidrug resistance has not been seen before in other species of Candida. Since 2009, C. auris has been found in patients in several countries, including the United States. CDC expects that as scientists continue to look for this fungus, more cases will be reported in the United States.
C. auris is difficult to identify with standard laboratory methods and can be misidentified in labs without specific technology. CDC encourages all U.S. laboratory staff who identify C. auris strains to notify their state or local public health authorities and CDC at email@example.com. Find answers to frequently asked questions about C. auris on our questions and answers page and in the Candida auris: Interim Recommendations.
CDC is working with state and local health departments to identify and investigate cases of C. auris. The following map displays where C. auris cases have been identified in the United States as of January 19, 2017. This map will be updated every two weeks.
- Vallabhaneni, S., et. al. Investigation of the first seven reported U.S. cases of Candida auris, a globally-emerging invasive fungus — United States, May 2013–August 2016 . MMWR, 2016, Nov 4.
- Lockhart, S., et al., Simultaneous emergence of multidrug resistant Candida auris on three continents confirmed by whole genome sequencing and epidemiological analyses. Clinical Infectious Dis, 2016, Oct 20.
- Sherry, L., et al., Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. Emerg Infect Dis, 2017.23(2): p. 328-31.
- European Centre for Disease Prevention and Control. Candida auris in healthcare settings – Europe – 19 December 2016. Stockholm: ECDC; 2016.
- Clancy, C.J., et al. Emergence of Candida auris: an international call-to-arms. Clinical Infectious Dis, 2016, Oct 20.
- Schelenz, S., et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016 Oct 19; 5:35.
- Calvo, B., et al. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect, 2016. 73(4): p.369-74.
- Candida auris identified in England. Public Health England. 2016, July 1.
- Candida auris: laboratory investigation, management and infection prevention and control. Public Health England. 2016, June 27.
- Emara, M., et al., Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis, 2015. 21(6): p. 1091-2.
- Magobo, R.E., et al., Candida auris-associated candidemia, South Africa. Emerg Infect Dis, 2014. 20(7): p. 1250-1.
- Chowdhary, A., et al., New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis, 2013. 19(10): p. 1670-3.
- Ben-Ami, R., et al., Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother, 2012. 56(5): p. 2518-23.
- Lee, W.G., et al., First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol, 2011. 49(9): p. 3139-42.
- Satoh, K., et al., Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol, 2009. 53(1): p. 41-4.
- Page last reviewed: November 4, 2016
- Page last updated: January 20, 2017
- Content source: